HOME >> MEDICINE >> NEWS
Combination therapy does not appear to benefit cardiac patients before heart catheter procedure

Patients with acute myocardial infarction (MI - heart attack) who are referred for percutaneous coronary intervention (such as angioplasty and stent placement in the coronary artery) do not have a reduction in the amount of damaged heart tissue when administered two drugs compared with a single drug to restore blood flow, according to a study in the February 25 issue of The Journal of the American Medical Association (JAMA).

According to background information in the article, "In hospitals with catheterization facilities, primary percutaneous coronary interventions (PCIs) are better then thrombolysis (drug therapy used to dissolve blood clots) in patients with ST-segment elevation acute MI. Specifically designed randomized trials have also shown that patients with acute MI presenting at hospitals without catheterization facilities benefit more from PCI performed after transfer to centers with catheterization laboratories than from on-site thombolysis."

Adnan Kastrati, M.D., from Deutsches Hezzentrum, Technische Universitat, Munich, Germany, and colleagues from the Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators, assessed whether early administration of the combination of the drugs reteplase plus abciximab produces better reduction of infarct size compared with abciximab alone in patients with acute MI referred for PCI. The study, conducted from May 3, 2001 through June 2, 2003, included 253 patients who were admitted to 13 community hospitals without catheterization facilities (n=186) and to 5 hospitals with catheterization facilities (n=67), within 12 hours of symptoms of an acute MI. Patients randomly received either the combination of reteplase and abciximab (n=125) or abciximab (n=128) alone. All patients were then transferred for PCI. Infarct size was later determined by imaging from a single-photon emission computed tomography (SPECT).

"The final infarct size of the left ventricle, the primary en
'"/>

Contact: Adnan Kastrati, M.D.
kastrati@dhm.mhn.de
JAMA and Archives Journals
24-Feb-2004


Page: 1 2

Related medicine news :

1. Combination treatment helps thyroid cancer patients live longer
2. Combination therapy, not medication alone, most effective for treating children with OCD
3. Combination of erection pill and testosterone gel may benefit men who fail treatment with pill alone
4. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
5. Combination PET/CT should be used to determine stage of non-small cell lung cancer
6. Combination of toxin and poison may be novel treatment for leukemia
7. Combination drug therapy could substantially improve symptoms of rheumatoid arthritis
8. Combination drug therapy offers hope for malaria treatment
9. Combination therapy significantly delays progression of benign prostatic hyperplasia
10. Combination, order of anti-HIV drugs make a difference in first-time recipients
11. Combination of HIV/malaria increases complications during pregnancy

Post Your Comments:
(Date:4/1/2015)... WI (PRWEB) April 01, 2015 When ... dryness occur, waiting days or weeks for an appointment ... Historically same and next day appointments haven’t been possible ... area, Forefront Dermatology’s offices have noticed demand for this ... , “We realize how important relief or answers to ...
(Date:4/1/2015)... GA (PRWEB) April 01, 2015 ... Medicine Practice, Pediatric Emergency Medicine Practice, and Hospital ... has partnered with AgileMD to provide the content ... , in a mobile application format available on ... , “Our collaboration with AgileMD to develop mobile ...
(Date:4/1/2015)... 01, 2015 On May 1, 2015, the ... annual Educational Institute in Albany, New York . This ... in nursing and feature an address by Helen R. Connors, ... Professor, University of Kansas School of Nursing and Center for ... being sponsored by the Excelsior College School of Nursing, ...
(Date:4/1/2015)... Washington, D.C. (PRWEB) April 01, 2015 It ... eaten solely for breakfast but now found wrapped around other ... products. Bacon has been called meat candy, the gateway meat ... as a cultural icon, the North American Meat Institute (NAMI) ... featuring a video tour of a bacon processing plant ...
(Date:4/1/2015)... 01, 2015 Natural fertility experts from ... attend the world’s first Integrative Fertility Symposium ( https://ifsymposium.com/ ... Centre (SFU Downtown Campus), 515 West Hastings Street, Vancouver ... Sunday, May 3rd, 3:00 pm to 5:00 pm at ... first of its kind in the world to bring ...
Breaking Medicine News(10 mins):Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3Health News:Excelsior College School of Nursing Educational Institute to Influence Nursing Empowerment 2Health News:Excelsior College School of Nursing Educational Institute to Influence Nursing Empowerment 3Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 3
(Date:4/1/2015)...  Salix Pharmaceuticals, Ltd. ("Salix"), a wholly owned ... VRX ) (TSX:VRX), today announced that it will ... amount of its 6.00% Senior Notes due 2021, ... pursuant to two redemptions. On May 1, 2015, ... the Notes, and on May 4, 2015, Salix ...
(Date:4/1/2015)... 1, 2015   AMC Health , a leading ... in monitored care that are transforming chronic care and ... Conference. The conference will be held at McCormick ... 12 through 16. In addition to demonstrating its partnerships ... Health will share innovations that transform the way healthcare ...
(Date:4/1/2015)... N.J. , April 1, 2015  Janssen Therapeutics, ... recipients of funding from a special request for applications ... Drugs Living with HIV and/or Hepatitis C." ... each will receive a one-year charitable contribution to enhance ... drugs living with HIV and/or hepatitis C. ...
Breaking Medicine Technology:Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 2AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 3AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 4Janssen Therapeutics Announces Support for Organizations Focused on Improving Care and Treatment for People Who Inject Drugs Living with HIV and/or Hepatitis C 2Janssen Therapeutics Announces Support for Organizations Focused on Improving Care and Treatment for People Who Inject Drugs Living with HIV and/or Hepatitis C 3Janssen Therapeutics Announces Support for Organizations Focused on Improving Care and Treatment for People Who Inject Drugs Living with HIV and/or Hepatitis C 4
Cached News: